US20020058971A1 - Cushioned primary coil for transcutaneous energy transfer - Google Patents
Cushioned primary coil for transcutaneous energy transfer Download PDFInfo
- Publication number
- US20020058971A1 US20020058971A1 US10/036,780 US3678001A US2002058971A1 US 20020058971 A1 US20020058971 A1 US 20020058971A1 US 3678001 A US3678001 A US 3678001A US 2002058971 A1 US2002058971 A1 US 2002058971A1
- Authority
- US
- United States
- Prior art keywords
- shield
- primary coil
- segments
- coil
- perforations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F38/00—Adaptations of transformers or inductances for specific applications or functions
- H01F38/14—Inductive couplings
Definitions
- This invention relates to transcutaneous energy transfer (TET) devices and, more particularly, to an improved primary coil for such device which reduces sensitivity to conductive objects in proximity of the TET.
- TET transcutaneous energy transfer
- These systems generally include an external primary coil and an implanted secondary coil, separated by an intervening layer of tissue.
- This design generally results in a loosely-coupled transformer with no magnetic shielding. Therefore, transformer parameters, such as mutual and self-inductance values, and the effective series resistance of each coil, can be altered by the presence of conductive objects, for example a metal plate, in the vicinity of the primary coil. Such parameter changes can result in undesired, and in some cases potentially catastrophic, variations in power delivered to the implanted device.
- an unshielded primary coil generates a magnetic field which is directed in substantially equal parts toward the secondary coil, where it performs useful work, and away from the secondary coil where the magnetic field energy is substantially wasted.
- the energy required to drive the TET device could be reduced. This could result in the device being driveable from a lower energy, and thus a smaller, lighter and less expensive source, or less drainage on could result in an existing source, facilitating longer battery life between replacement or recharging.
- Such a device and method would significantly enhance the energy transfer efficiency of the TET device.
- this invention provides a transcutaneous energy transfer device having an external primary coil to which energy to be transferred is applied and an implanted secondary coil inductively coupled to the primary coil and connected to apply energy to a subcutaneous utilization device, the invention being characterized by the inclusion of a magnetic shield covering the primary winding.
- the shape of the shield is generally substantially the same as that of the primary coil, but the size of the shield should be greater than that of the primary coil. More particularly, to fully reflect magnetic field toward the secondary coil, the shield should overlap the primary coil on all sides by at least the thickness (t) of the shield.
- the shield has a generally circular shape with a diameter D, where D>d and preferably D ⁇ d+2t.
- the thickness of the shield for a circular shield is preferably much greater than D/ ⁇ where ⁇ is the magnetic permeability relative to free space of the shield material, or more generally, t>>X/ ⁇ , where X is a major dimension of the shield.
- the shield normally has a plurality of ventilation perforations formed therein which perforations are preferably formed parallel to the magnetic field direction so that the path taken through the material of the shield is as short as possible.
- the perforations are a plurality of radial slots, which slots are slightly wedge-shaped for an illustrative embodiment.
- the shield should also be flexible so as to be able to conform to the contours of a patient's body.
- the shield is formed of a low loss magnetic material in a flexible polymer matrix, the shield being formed of a ferrite powder in a silicon rubber for an illustrative embodiment.
- the shield is formed of a plurality of segments of a very high permeability material connected by a porous, flexible material. To the extent there are spacings between adjacent segments in a direction substantially perpendicular to the primary coil magnetic field in order to enhance flexibility, such spacings are much smaller than spacings in a direction parallel to the magnetic field.
- the shield is also dimensioned and formed of a material which reflects most of the magnetic field directed away from the secondary coil back toward the secondary coil. This significantly enhances the efficiency of energy transfer across the skin boundary by the TET device.
- the segments include a plurality of segments arranged in one or more concentric rings, each said concentric ring including segments of substantially the same size.
- the plurality of segments are constructed and arranged so as to form a gap between radially opposing segments in said ring.
- the segments further include a center disk shaped to fit within said gap.
- the shield and said primary coil are mounted together to form a primary coil assembly.
- a substantially impervious coating is applied to the assembly to make it substantially waterproof and easy to clean.
- the primary coil assembly is vinyl dip coated.
- the primary coil is operationally decoupled from a drive circuit prior to physical disconnection of electrical contacts through which current is transferred from the drive circuitry to said primary coil.
- the physical connection of electrical contacts through which current is transferred from the drive circuitry to said primary coil occurs prior to operationally coupled the primary winding to the drive circuit.
- the primary coil is electrically coupled to the drive circuit via an electrical connector.
- the electrical connector includes power transfer contacts and anti-arcing contacts. The anti-arcing contacts electrically mate after and break before said power transfer contacts, and are electrically connected to control circuitry operationally interposed between the drive circuit from the primary winding.
- the control circuitry is located in said drive circuitry while in another embodiment, it is located in the connector.
- FIG. 1 is a side cutaway view of a TET coil pair with a magnetically shielded primary coil in accordance with the teachings of this invention
- FIG. 2 is a top view of a shield shown in FIG. 1 for one embodiment of the invention.
- FIGS. 3 and 4 are partial top views of the shield shown in FIG. 1 for two alternative embodiments of the invention.
- FIG. 5 is a top view of still another embodiment of the invention.
- FIG. 6A is an alternative embodiment of a shield having a tiled ferrite design.
- FIG. 6B is another alternative embodiment a shield having a tiled ferrite design.
- FIG. 7A is a cross-sectional view of one embodiment of a primary coil assembly that is providing a comfortable interface between the TET Primary coil and skin.
- FIG. 7B is an alternative embodiment of the cushion illustrated in FIG. 7A.
- FIG. 8 is a schematic block diagram of a connector for electrically connecting a drive circuit with the primary coil in accordance with one embodiment of the present invention.
- FIG. 1 shows a primary coil 10 having a diameter d and a secondary coil 12 having a diameter d 2 , where d 2 ⁇ d, of a TET device for transferring energy through a skin boundary 14 .
- a standard TET device has at least two shortcomings.
- the magnetic field of primary coil 10 normally generates substantially equal magnetic fields in directions both toward and away from secondary coil 12 .
- a conductive object in the vicinity of primary coil 10 and in particular a conductive object passing through the magnetic field of this coil, can alter parameters of the coil such as its self-inductance values and effective series resistance, thus resulting in a variation in the energy transferred to secondary coil 12 . Since it is desired that this energy transfer be substantially uniform, the potential for spurious variations in energy transfer is at best undesirable, and at worst can have potentially catastrophic consequences for the patient.
- a second problem is that energy is required to generate the magnetic field in the direction away from the secondary coil and, since this magnetic field does not contribute to the energy transfer, device efficiency is reduced. Stated another way, the fact that half the magnetic field generated by the primary coil is not being utilized for energy transfer substantially increases the amount of energy which must be applied to the primary coil in order to achieve a desired energy level at the secondary coil.
- shield 16 mounted over primary windings 10 .
- the shape of shield 16 is preferably substantially the same as that of primary coil 10 , although this is by no means a limitation on the invention.
- the size of the shield is also preferably greater than that of the primary winding.
- both primary winding 10 and shield 16 have a generally circular shape, with the diameter D of the shield shown as being greater than the diameter d of the coil.
- shield 16 should overlap primary coil 10 on all sides by at least the thickness (t) of the shield.
- t thickness
- Shield 16 is preferably formed of a low loss magnetic material. This results in the magnetic field emanating from primary coil 10 in the direction of shield 16 being substantially reflected with minimum absorption by shield 16 , back toward secondary coil 12 . With D ⁇ d+2t, substantially all of the magnetic field from the primary coil can be either directed or reflected to the secondary coil 12 , substantially increasing the transfer efficiency of the TET device, this efficiency theoretically being substantially doubled.
- shield 16 is therefore preferably a low loss magnetic material in a flexible polymer matrix.
- ferrite powder (Steward MnZn loading powder #73300) is embedded in a silicone rubber in a ratio by weight of 9 parts silicone to 12 parts ferrite powder. Since the polymer in which the magnetic material is embedded significantly reduces the magnetic permeability of the material (the reduction being by a factor of 10 for the illustrative composition), it is desirable incorporate as much ferrite powder as possible while retaining the required flexibility of the shield.
- the TET device may remain in place for a substantial period of time, it is important that the skin of the patient under shield 16 be able to “breathe”, or in other words that air be allowed access to this skin, in order to prevent skin degeneration. It is therefore important that perforation holes be provided in shield 16 . Since any openings in the shield may permit potential magnetic field leakage above the shield, the perforations are preferably parallel to the magnetic field in order to minimize magnetic flux paths through the shield material, thus enhancing reflection and minimizing leakage. For the embodiments of FIGS. 2 - 4 wherein shield 16 is substantially circular, to achieve this objective, the perforations are implemented in a substantially radial manner, as shown. With other primary coil shapes, the perforation pattern may very well be different.
- FIG. 4 The smaller and thinner the perforations, the less potential there is for magnetic field leakage, so that the arrangement shown in FIG. 4, with a radially arranged series of small holes 18 is preferable from a shielding standpoint.
- the arrangement of FIG. 4 may not provide sufficient ventilation for long-term usage, Alternatively, an arrangement such as that shown in FIG. 3, with radial slots 20 which are relatively thin to the magnetic field path so as to preventing significantly magnetic field leakage, while still providing reasonable ventilation. More specifically, it has been found that, in order to achieve adequate ventilation, the perforations should make up between 25% and 75% of the area of the shield, with perforations comprising approximately 50% of the area of the shield being generally preferred for long-term usage. This may require a configuration such as that shown in FIG.
- the perforations reduce ⁇ r for this shield from what it would be without the perforation.
- the amount of such a reduction is generally in direct proportion to the percentage of the surface area of the shield absorbed by such perforations.
- a limitation on perforation size is that the perforation size is small compared to the size of the smallest coil in the TET device. Referring to the device of FIG. 1, for example, the size of the individual perforations are much smaller than that of secondary coil 12 . For example, if the diameter d 2 of the secondary coil is roughly 1.5 inches, the perforations should be less than approximately 33% of the diameter d 2 or 0.5 inches in their smallest dimension. In other embodiments, the smallest dimension of the perforations is preferably less than approximately 20% of the diameter d 2 ; in other embodiments, the smallest dimension of the perforations is between approximately 20-60% of the diameter d 2 .
- shield thickness as well as size and shape of the perforations may be adjusted to minimize magnetic field leakage through shield 16 , and thus to minimize the interference or loss of energy transfer efficiency caused by a conducting object near or in contact with the shield, it is desirable in any event that the perforations not result in a decrease in coupling efficiency of greater than 20%, and preferably less than 16%, when a conducting object is brought in close proximity of the shield.
- FIG. 5 illustrates a shield 24 which differs from the shields 16 previously discussed in that, instead of being formed of a piece of flexible material having perforations or openings 18 - 22 , formed therein, the shield is formed of segments 26 of a very high permeability but inflexible material, such as a hard ferrite, which segments are connected to each other with a breathable and porous mesh 28 of a polymer or other flexible material. Since the effective ⁇ r of the segments 26 is much higher than that of the material used in the flexible shield 16 , the shield may be made substantially thinner than for the prior embodiments while still satisfying the requirement that t>>D/ ⁇ r .
- the high ⁇ r segments 26 permit a larger percentage of the area of the shield to be covered by mesh 28 while still achieving desired shielding, enhancing breathability and protecting against skin degeneration. Segments 26 may take up 25-75% of the shield area, but would typically take up 50% or less of such area.
- the radial spacings between segments would, as previously indicated, have a smallest dimension less than the diameter of the secondary coil, and might, for example be 0.5 inches for a roughly 1.5 inch secondary coil.
- the circular spacing which is required to obtain flexibility in all dimensions for the shield, which spacing is perpendicular to the magnetic field of coil 10 , should be much thinner, and for the dimensions above would typically be approximately 0.1 inches.
- the embodiment shown in FIG. 5 may be the preferred embodiment.
- FIG. 6A is an alternative embodiment of a shield having a tiled ferrite design.
- shield 600 includes multiple concentric rows of segments 602 . Segments 602 in inner concentric row 604 are small relative to segments 602 in outer concentric row 606 . In should be understood that any number of concentric rows may be implemented.
- FIG. 6B is a further an alternative embodiment a shield having a tiled ferrite design.
- shield 650 includes multiple concentric rows of segments 652 similar to segments 26 in shield 24 shown in FIG. 5.
- the center disk segment is omitted.
- the large open space 654 in the center of the shield 650 aligned approximately with the center of the primary coil reduces minimally the coupling efficiency of the device while improving the skin ventilation under the primary coil. It should be understood that the size of the center space 654 may have any dimensions suitable for a desired coupling efficiency.
- FIG. 7A is a cross-sectional view of one embodiment of a primary coil assembly 700 that is configured to provide a comfortable interface between the TET Primary coil 10 and skin 14 with a low-cost, disposable part that can easily be removed and replaced.
- Primary coil assembly 700 includes primary coil 10 and ferrite shield 16 , as described above.
- primary coil assembly 700 is a compliant skin-compatible cushion 702 .
- Cushion 702 is preferably ventilated to relieve perspiration and provide for cooling of the skin 14 .
- cushion 702 is preferably disposable so that it can easily be removed and replaced when it becomes soiled.
- cushion 702 one embodiment of cushion 702 is illustrated.
- a hook and loop fastening material 704 such as VELCRO is fastened to the side of primary coil 10 opposite shield 701 , schematically shown in FIG. 7A. This provides for the easily attachment and detachment of cushion 702 .
- Cushion 702 includes 3 layers in the illustrative embodiment.
- a VELCRO loop material 706 adapted to be attached to VELCRO hook material 704 .
- An open cell foam material 708 for providing compliance and breathability is bonded to loop material 706 .
- a skin-compatible material 710 such as terry-cloth is bonded to open cell foam layer 708 to provide a ventilated, non-allergenic, non-irritating skin contacting surface.
- the above construction enables cushion 702 be formed from a low-cost, die-cut part.
- FIG. 7B is an alternative embodiment of the cushion according to this aspect of the present invention.
- a cushion 750 is a laminate similar in construction to cushion 712 .
- the open cell material 708 is crenellated to provide increased ventilation between the cushion surface and the skin 14 .
- the skin-compatible layer 756 is bonded to open cell foam layer 654 and, therefore, follows crenelate surface of foam layer 754 .
- skin-contact material 756 may be constructed so as to serve a s a wick to draw perspiration from the skin.
- the shield and primary coil 10 are mounted together is some known manner and a impervious coating is applied to make the shield and TET primary coil more durable, waterproof, and washable.
- a impervious coating is applied to make the shield and TET primary coil more durable, waterproof, and washable.
- vinyl dip coating is used.
- FIG. 8 is a schematic block diagram of another aspect of the present invention.
- a primary coil assembly 802 is detachable from drive electronics 804 that control the primary coil 10 within the primary coil assembly 802 .
- the drive circuitry 804 is automatically disabled before disconnecting power transfer contacts for the primary coil 10 , and automatically enabled only after connecting the power transfer contacts for the primary coil 10 .
- a spare separate set 808 of contacts 810 in the connector 806 are constructed and arranged to mate last and break first relative to the one or more contacts 812 that provide power to primary coil 10 .
- the anti-arching contacts 808 are connected to well-known circuitry 818 that enables or disables the drive circuitry 804 , shown schematically as a relay interposed between a voltage source and receiving power transfer contacts 814 .
- the anti-arching contacts 808 in connector 806 have a length that is shorter than the power transfer contacts 812 .
- receiving power transfer contacts 814 that receive contacts 812 are longer than receiving anti-arching contacts 816 that receive anti-arching contacts 808 .
- This embodiment therefore, enables the TET drive circuitry 804 to be automatically disabled before disconnecting the power transfer contacts for the primary coil 10 while automatically turning on the primary coil 10 after reconnection of the coil power transfer contacts 812 and 814 .
- other schemes may be implemented to perform this function.
- a latches may be used to connect male and female portions of a high frequency connector coupling drive circuitry 804 and primary coil assembly 802 . The latch would be electrically connected to well-known circuitry that would enable or disable the drive circuitry similar to that described above.
- control circuitry 818 may be located in drive circuitry 804 , primary coil assembly 802 or connector 806 , depending on the application.
- Such automatic connect/disconnect feature allows for greater flexibility.
- the primary coil 10 may be sterilized easily for use during implant surgery.
- it would also allow the patient to wear just the TET primary coil assembly without all of the battery powered electronics, as well as to plug the primary coil into power sources located at convenient places in the home or work environment.
- separation of the drive circuitry 804 eliminates the weight of the patient-carried electronics and battery pack. This is important, for example, for patients who are physically very weakened.
Abstract
A transcutaneous energy transfer device is provided which has a magnetic shield covering the primary winding of the device to reduce sensitivity of the device to conducting objects in the vicinity of the coils and to increase the percentage of magnetic field generated by the primary coil which reaches the secondary coil. This shield is preferably larger than the primary coil in all dimensions and is either formed of a high permeability flexible material, for example a low loss magnetic material in a flexible polymer matrix, with perforations formed in the material sufficient to permit ventilation of the patient's skin situated under the shield, or the shield may be formed of segments of very high permeability material connected by a flexible, porous mesh material.
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 09/110,608 filed Jul. 6, 1998 entitled “MAGNEIC SHIELD FOR PRIMARY COIL OF TRANSCUTANEOUS ENERGY TRANSFER DEVICE,” and naming as inventors Fred Zarinetchi and Steven J. Keville, now currently pending.
- The following commonly-owned application is related to the present application and its disclosure is incorporated by reference in the present application:
- U.S. patent application Ser. No. 09/110,607, filed Jul. 6, 1998, entitled “TET WITH MAGNETIC FIELD PROTECTED COMPONENTS IN SECONDARY COIL,” naming as inventors Fred Zarinetchi and Robert M. Hart, and now pending.
- This invention relates to transcutaneous energy transfer (TET) devices and, more particularly, to an improved primary coil for such device which reduces sensitivity to conductive objects in proximity of the TET.
- Many medical devices are now designed to be implantable, including pacemakers, defibrillators, circulatory assist devices, cardiac replacement devices such as artificial hearts, cochlea implants, neuromuscular simulators, biosensors, and the like. Since almost all of the active devices (i.e., those that perform work) and many of the passive devices (i.e., those that do not perform work) require a source of power, inductively coupled transcutaneous energy transfer (TET) devices and information transmission systems for such devices are coming into increasing use.
- These systems generally include an external primary coil and an implanted secondary coil, separated by an intervening layer of tissue. This design generally results in a loosely-coupled transformer with no magnetic shielding. Therefore, transformer parameters, such as mutual and self-inductance values, and the effective series resistance of each coil, can be altered by the presence of conductive objects, for example a metal plate, in the vicinity of the primary coil. Such parameter changes can result in undesired, and in some cases potentially catastrophic, variations in power delivered to the implanted device. Further, an unshielded primary coil generates a magnetic field which is directed in substantially equal parts toward the secondary coil, where it performs useful work, and away from the secondary coil where the magnetic field energy is substantially wasted. If a higher percentage of the magnetic field from the primary coil could be directed to the implanted secondary coil, the energy required to drive the TET device could be reduced. This could result in the device being driveable from a lower energy, and thus a smaller, lighter and less expensive source, or less drainage on could result in an existing source, facilitating longer battery life between replacement or recharging.
- A need therefore exists for an improved primary coil construction for a TET device which both reduces sensitivity of the device to conducting objects in the vicinity of the coils and, preferably, which increases the percentage of magnetic field generated by the primary coil which reaches the secondary coil. Such a device and method would significantly enhance the energy transfer efficiency of the TET device.
- In accordance with the above, this invention provides a transcutaneous energy transfer device having an external primary coil to which energy to be transferred is applied and an implanted secondary coil inductively coupled to the primary coil and connected to apply energy to a subcutaneous utilization device, the invention being characterized by the inclusion of a magnetic shield covering the primary winding. The shape of the shield is generally substantially the same as that of the primary coil, but the size of the shield should be greater than that of the primary coil. More particularly, to fully reflect magnetic field toward the secondary coil, the shield should overlap the primary coil on all sides by at least the thickness (t) of the shield. Where the primary coil has a generally circular shape with a diameter d, the shield has a generally circular shape with a diameter D, where D>d and preferably D≧d+2t. The thickness of the shield for a circular shield is preferably much greater than D/μ where μ is the magnetic permeability relative to free space of the shield material, or more generally, t>>X/μ, where X is a major dimension of the shield.
- The shield normally has a plurality of ventilation perforations formed therein which perforations are preferably formed parallel to the magnetic field direction so that the path taken through the material of the shield is as short as possible. For embodiments where the primary coil is circular, the perforations are a plurality of radial slots, which slots are slightly wedge-shaped for an illustrative embodiment. To assure adequate ventilation, the perforations should make up between approximately 25% and 75% of the shield area. Since the perforations reduce μ of the shield material, for the shield thickness to continue to satisfy t>>X/μ, t needs to increase proportionally (i.e., if the shield is 50% perforated, shield thickness tp=2t). Perforation size should also be small compared the smallest coil in the TET device.
- The shield should also be flexible so as to be able to conform to the contours of a patient's body. To achieve this flexibility, for one embodiment of the invention the shield is formed of a low loss magnetic material in a flexible polymer matrix, the shield being formed of a ferrite powder in a silicon rubber for an illustrative embodiment. For another embodiment, the shield is formed of a plurality of segments of a very high permeability material connected by a porous, flexible material. To the extent there are spacings between adjacent segments in a direction substantially perpendicular to the primary coil magnetic field in order to enhance flexibility, such spacings are much smaller than spacings in a direction parallel to the magnetic field.
- The shield is also dimensioned and formed of a material which reflects most of the magnetic field directed away from the secondary coil back toward the secondary coil. This significantly enhances the efficiency of energy transfer across the skin boundary by the TET device.
- In one embodiment the segments include a plurality of segments arranged in one or more concentric rings, each said concentric ring including segments of substantially the same size. In another embodiment, the plurality of segments are constructed and arranged so as to form a gap between radially opposing segments in said ring. In this embodiment, the segments further include a center disk shaped to fit within said gap.
- In anther aspect of the invention, the shield and said primary coil are mounted together to form a primary coil assembly. A substantially impervious coating is applied to the assembly to make it substantially waterproof and easy to clean. In one particular embodiment, the primary coil assembly is vinyl dip coated.
- In another aspect of the invention, the primary coil is operationally decoupled from a drive circuit prior to physical disconnection of electrical contacts through which current is transferred from the drive circuitry to said primary coil. The physical connection of electrical contacts through which current is transferred from the drive circuitry to said primary coil occurs prior to operationally coupled the primary winding to the drive circuit. In one implementation, the primary coil is electrically coupled to the drive circuit via an electrical connector. The electrical connector includes power transfer contacts and anti-arcing contacts. The anti-arcing contacts electrically mate after and break before said power transfer contacts, and are electrically connected to control circuitry operationally interposed between the drive circuit from the primary winding. In one embodiment, the control circuitry is located in said drive circuitry while in another embodiment, it is located in the connector.
- Further features and advantages of the present invention as well as the structure and operation of various embodiments of the present invention are described in detail below with reference to the accompanying drawings. In the drawings, like reference numerals indicate like or functionally similar elements. Additionally, the left-most one or two digits of a reference numeral identifies the drawing in which the reference numeral first appears.
- This invention is pointed out with particularity in the appended claims. The above and further advantages of this invention may be better understood by referring to the following description when taken in conjunction with the accompanying drawings, in which:
- FIG. 1 is a side cutaway view of a TET coil pair with a magnetically shielded primary coil in accordance with the teachings of this invention;
- FIG. 2 is a top view of a shield shown in FIG. 1 for one embodiment of the invention; and
- FIGS. 3 and 4 are partial top views of the shield shown in FIG. 1 for two alternative embodiments of the invention.
- FIG. 5 is a top view of still another embodiment of the invention.
- FIG. 6A is an alternative embodiment of a shield having a tiled ferrite design.
- FIG. 6B is another alternative embodiment a shield having a tiled ferrite design.
- FIG. 7A is a cross-sectional view of one embodiment of a primary coil assembly that is providing a comfortable interface between the TET Primary coil and skin.
- FIG. 7B is an alternative embodiment of the cushion illustrated in FIG. 7A.
- FIG. 8 is a schematic block diagram of a connector for electrically connecting a drive circuit with the primary coil in accordance with one embodiment of the present invention.
- FIG. 1 shows a
primary coil 10 having a diameter d and asecondary coil 12 having a diameter d2, where d2<d, of a TET device for transferring energy through askin boundary 14. As indicated previously, such a standard TET device has at least two shortcomings. First, the magnetic field ofprimary coil 10 normally generates substantially equal magnetic fields in directions both toward and away fromsecondary coil 12. This means that a conductive object in the vicinity ofprimary coil 10, and in particular a conductive object passing through the magnetic field of this coil, can alter parameters of the coil such as its self-inductance values and effective series resistance, thus resulting in a variation in the energy transferred tosecondary coil 12. Since it is desired that this energy transfer be substantially uniform, the potential for spurious variations in energy transfer is at best undesirable, and at worst can have potentially catastrophic consequences for the patient. - A second problem is that energy is required to generate the magnetic field in the direction away from the secondary coil and, since this magnetic field does not contribute to the energy transfer, device efficiency is reduced. Stated another way, the fact that half the magnetic field generated by the primary coil is not being utilized for energy transfer substantially increases the amount of energy which must be applied to the primary coil in order to achieve a desired energy level at the secondary coil.
- Aspects of the present invention overcome these problems by providing a
magnetic shield 16 mounted overprimary windings 10. The shape ofshield 16 is preferably substantially the same as that ofprimary coil 10, although this is by no means a limitation on the invention. The size of the shield is also preferably greater than that of the primary winding. Thus, in FIG. 1 it is assumed that both primary winding 10 andshield 16 have a generally circular shape, with the diameter D of the shield shown as being greater than the diameter d of the coil. More specifically, to fully reflect magnetic field toward the secondary coil, shield 16 should overlapprimary coil 10 on all sides by at least the thickness (t) of the shield. Thus, for a circular shield, it is preferable that D≧d+2t. For a non-circular coil, having various dimensions xi, the corresponding dimension for the shield would in each instance be Xi≧xi+2t. - The thickness (t) of
shield 16 should be much greater than X/μr where μr is the magnetic permeability of the magnetic shield material relative to free space and X is a major dimension of the shield. Therefore, for the circular shield of the figures, t>>D/μr. For an illustrative embodiment, D=5.5″, d=5″, t=0.25″ and μr is approximately 100. However, the dimensions of the shield will vary significantly depending on the application. -
Shield 16 is preferably formed of a low loss magnetic material. This results in the magnetic field emanating fromprimary coil 10 in the direction ofshield 16 being substantially reflected with minimum absorption byshield 16, back towardsecondary coil 12. With D≧d+2t, substantially all of the magnetic field from the primary coil can be either directed or reflected to thesecondary coil 12, substantially increasing the transfer efficiency of the TET device, this efficiency theoretically being substantially doubled. - While in FIG. 1 the
skin surface 14 is shown as being substantially flat, as a practical matter, the skin surface in most applications of this invention will be curved in various ways, requiring thatshield 16 be flexible so as to be able to conform to the contours of the skin surface in the transfer area. The material forshield 16 is therefore preferably a low loss magnetic material in a flexible polymer matrix. For one illustrative embodiment of the invention, ferrite powder (Steward MnZn loading powder #73300) is embedded in a silicone rubber in a ratio by weight of 9 parts silicone to 12 parts ferrite powder. Since the polymer in which the magnetic material is embedded significantly reduces the magnetic permeability of the material (the reduction being by a factor of 10 for the illustrative composition), it is desirable incorporate as much ferrite powder as possible while retaining the required flexibility of the shield. - Since the TET device may remain in place for a substantial period of time, it is important that the skin of the patient under
shield 16 be able to “breathe”, or in other words that air be allowed access to this skin, in order to prevent skin degeneration. It is therefore important that perforation holes be provided inshield 16. Since any openings in the shield may permit potential magnetic field leakage above the shield, the perforations are preferably parallel to the magnetic field in order to minimize magnetic flux paths through the shield material, thus enhancing reflection and minimizing leakage. For the embodiments of FIGS. 2-4 whereinshield 16 is substantially circular, to achieve this objective, the perforations are implemented in a substantially radial manner, as shown. With other primary coil shapes, the perforation pattern may very well be different. The smaller and thinner the perforations, the less potential there is for magnetic field leakage, so that the arrangement shown in FIG. 4, with a radially arranged series ofsmall holes 18 is preferable from a shielding standpoint. However, the arrangement of FIG. 4 may not provide sufficient ventilation for long-term usage, Alternatively, an arrangement such as that shown in FIG. 3, withradial slots 20 which are relatively thin to the magnetic field path so as to preventing significantly magnetic field leakage, while still providing reasonable ventilation. More specifically, it has been found that, in order to achieve adequate ventilation, the perforations should make up between 25% and 75% of the area of the shield, with perforations comprising approximately 50% of the area of the shield being generally preferred for long-term usage. This may require a configuration such as that shown in FIG. 2, with generally radially-arranged, wedge-shapedslots 22 to increase the perforation area. However, since the perforations reduce μr for this shield from what it would be without the perforation. The amount of such a reduction is generally in direct proportion to the percentage of the surface area of the shield absorbed by such perforations. This, in combination with the above-noted objective that t>>D/μr, the thickness t should generally be increased is some relationship with the increase in surface area dedicated to the perforations. For example, in one embodiment wherein the perforations comprise 50% of the shield area, the shield thickness tp has been increased such that tp=2t. Other linear and non-linear relationships between shield thickness and surface area absorbed by the perforations. - In one aspect of the invention, a limitation on perforation size is that the perforation size is small compared to the size of the smallest coil in the TET device. Referring to the device of FIG. 1, for example, the size of the individual perforations are much smaller than that of
secondary coil 12. For example, if the diameter d2 of the secondary coil is roughly 1.5 inches, the perforations should be less than approximately 33% of the diameter d2 or 0.5 inches in their smallest dimension. In other embodiments, the smallest dimension of the perforations is preferably less than approximately 20% of the diameter d2; in other embodiments, the smallest dimension of the perforations is between approximately 20-60% of the diameter d2. While shield thickness as well as size and shape of the perforations may be adjusted to minimize magnetic field leakage throughshield 16, and thus to minimize the interference or loss of energy transfer efficiency caused by a conducting object near or in contact with the shield, it is desirable in any event that the perforations not result in a decrease in coupling efficiency of greater than 20%, and preferably less than 16%, when a conducting object is brought in close proximity of the shield. - FIG. 5 illustrates a
shield 24 which differs from theshields 16 previously discussed in that, instead of being formed of a piece of flexible material having perforations or openings 18-22, formed therein, the shield is formed ofsegments 26 of a very high permeability but inflexible material, such as a hard ferrite, which segments are connected to each other with a breathable andporous mesh 28 of a polymer or other flexible material. Since the effective μr of thesegments 26 is much higher than that of the material used in theflexible shield 16, the shield may be made substantially thinner than for the prior embodiments while still satisfying the requirement that t>>D/μr. Thus, a thickness in the order of ⅛ inch or less forshield 24 might be possible, making the shield much more comfortable for the wearer. Further, the high μr segments 26 permit a larger percentage of the area of the shield to be covered bymesh 28 while still achieving desired shielding, enhancing breathability and protecting against skin degeneration.Segments 26 may take up 25-75% of the shield area, but would typically take up 50% or less of such area. The radial spacings between segments would, as previously indicated, have a smallest dimension less than the diameter of the secondary coil, and might, for example be 0.5 inches for a roughly 1.5 inch secondary coil. However, the circular spacing, which is required to obtain flexibility in all dimensions for the shield, which spacing is perpendicular to the magnetic field ofcoil 10, should be much thinner, and for the dimensions above would typically be approximately 0.1 inches. For many applications, the embodiment shown in FIG. 5 may be the preferred embodiment. - FIG. 6A is an alternative embodiment of a shield having a tiled ferrite design. In this embodiment,
shield 600 includes multiple concentric rows ofsegments 602.Segments 602 in innerconcentric row 604 are small relative tosegments 602 in outerconcentric row 606. In should be understood that any number of concentric rows may be implemented. - FIG. 6B is a further an alternative embodiment a shield having a tiled ferrite design. In this embodiment,
shield 650 includes multiple concentric rows ofsegments 652 similar tosegments 26 inshield 24 shown in FIG. 5. However, in this embodiment, the center disk segment is omitted. The largeopen space 654 in the center of theshield 650 aligned approximately with the center of the primary coil reduces minimally the coupling efficiency of the device while improving the skin ventilation under the primary coil. It should be understood that the size of thecenter space 654 may have any dimensions suitable for a desired coupling efficiency. - FIG. 7A is a cross-sectional view of one embodiment of a
primary coil assembly 700 that is configured to provide a comfortable interface between theTET Primary coil 10 andskin 14 with a low-cost, disposable part that can easily be removed and replaced.Primary coil assembly 700 includesprimary coil 10 andferrite shield 16, as described above. To prevent adverse effects due to having such a rigid device continually against a same region of theskin 14,primary coil assembly 700 is a compliant skin-compatible cushion 702. Cushion 702 is preferably ventilated to relieve perspiration and provide for cooling of theskin 14. In addition cushion 702 is preferably disposable so that it can easily be removed and replaced when it becomes soiled. - Referring to FIG. 7A, one embodiment of cushion702 is illustrated. A hook and loop fastening material 704 such as VELCRO is fastened to the side of
primary coil 10opposite shield 701, schematically shown in FIG. 7A. This provides for the easily attachment and detachment of cushion 702. Cushion 702 includes 3 layers in the illustrative embodiment. AVELCRO loop material 706 adapted to be attached to VELCRO hook material 704. An opencell foam material 708 for providing compliance and breathability is bonded toloop material 706. A skin-compatible material 710 such as terry-cloth is bonded to opencell foam layer 708 to provide a ventilated, non-allergenic, non-irritating skin contacting surface. The above construction enables cushion 702 be formed from a low-cost, die-cut part. - FIG. 7B is an alternative embodiment of the cushion according to this aspect of the present invention. In this embodiment, a
cushion 750 is a laminate similar in construction to cushion 712. In this embodiment, however, theopen cell material 708 is crenellated to provide increased ventilation between the cushion surface and theskin 14. The skin-compatible layer 756 is bonded to opencell foam layer 654 and, therefore, follows crenelate surface offoam layer 754. It should be understood that other well-known materials may be used. For example, skin-contact material 756 may be constructed so as to serve a s a wick to draw perspiration from the skin. - In alternative embodiments, the shield and
primary coil 10 are mounted together is some known manner and a impervious coating is applied to make the shield and TET primary coil more durable, waterproof, and washable. In one particular embodiment, for example, vinyl dip coating is used. - FIG. 8 is a schematic block diagram of another aspect of the present invention. In this aspect of the invention, a
primary coil assembly 802 is detachable fromdrive electronics 804 that control theprimary coil 10 within theprimary coil assembly 802. To avoid degradation of the high current connector as a result of arching during live connecting/disconnection of theprimary coil assembly 802 and drivecircuitry 804, thedrive circuitry 804 is automatically disabled before disconnecting power transfer contacts for theprimary coil 10, and automatically enabled only after connecting the power transfer contacts for theprimary coil 10. - In the illustrative embodiment illustrated in FIG. 8, for example, a spare
separate set 808 ofcontacts 810 in theconnector 806 are constructed and arranged to mate last and break first relative to the one ormore contacts 812 that provide power toprimary coil 10. Theanti-arching contacts 808 are connected to well-known circuitry 818 that enables or disables thedrive circuitry 804, shown schematically as a relay interposed between a voltage source and receivingpower transfer contacts 814. In particular, in order to mate last and break first, theanti-arching contacts 808 inconnector 806 have a length that is shorter than thepower transfer contacts 812. In addition, receivingpower transfer contacts 814 that receivecontacts 812 are longer than receivinganti-arching contacts 816 that receiveanti-arching contacts 808. This embodiment, therefore, enables theTET drive circuitry 804 to be automatically disabled before disconnecting the power transfer contacts for theprimary coil 10 while automatically turning on theprimary coil 10 after reconnection of the coilpower transfer contacts coupling drive circuitry 804 andprimary coil assembly 802. The latch would be electrically connected to well-known circuitry that would enable or disable the drive circuitry similar to that described above. Operation of the latch to disconnect the two connector halves would cause thedrive circuitry 804 to be disabled and the power throughcontacts 812 to be removed prior to when thecontacts 812 are physically disconnected from the receivingcontacts 814. Similarly,contacts 812 would first come into physical contact with receivingcontacts 814 beforeanti-arching contacts 810 come into contact with corresponding receivingcontacts 816. This subsequent contact would cause automatically thedrive circuitry 804 to become operational allowing power to travel throughcontacts 812. It should also be understood that virtually any other type of electrical circuit switch or other on/off device may be used to operationally disconnectprimary coil 10 anddrive circuitry 804 prior to the decoupling of thecontacts primary coil 10 anddrive circuitry 804 after the connection ofcontacts - It should also be understood that control circuitry818 may be located in
drive circuitry 804,primary coil assembly 802 orconnector 806, depending on the application. - Such automatic connect/disconnect feature allows for greater flexibility. For example, the
primary coil 10 may be sterilized easily for use during implant surgery. In addition, it would also allow the patient to wear just the TET primary coil assembly without all of the battery powered electronics, as well as to plug the primary coil into power sources located at convenient places in the home or work environment. Further, separation of thedrive circuitry 804 eliminates the weight of the patient-carried electronics and battery pack. This is important, for example, for patients who are physically very weakened. - While the invention has been particularly shown and described above with reference to several preferred embodiments and variations thereon, it is to be understood that additional variations could be made in the invention by those skilled in the art while still remaining within the spirit and scope of the invention, and that the invention is intended to include any such variations, being limited only by the scope of the appended claims.
- Further information is described in currently pending U.S. patent application Ser. No. 09/110,608 filed Jul. 6, 1998 entitled “MAGNETIC SHIELD FOR PRIMARY COIL OF TRANSCUTANEOUS ENERGY TRANSFER DEVICE,” and naming as inventors Fred Zarinetchi and Steven J. Keville, now currently pending, incorporated herein by reference in its entirety.
Claims (30)
1. A transcutaneous energy transfer device having an external primary coil to which energy to be transferred is applied, and an implanted secondary coil inductively coupled to said primary coil and connected to apply energy to a subcutaneous utilization device, characterized by the inclusion of a magnetic shield covering said primary winding.
2. A device as claimed in claim 1 wherein said shield is larger than said primary coil.
3. A device as claimed in claim 2 wherein said primary coil has a selected shape and size, and wherein said shield is of substantially the same shape as said primary coil, but of greater size.
4. A device as claimed in claim 3 wherein said primary coil has dimensions xi in direction i, wherein the shield has a thickness t and wherein the dimensions of the shield in direction i is Xi≧xi+2t.
5. A device as claimed in claim 3 wherein said primary coil has a generally circular shape with a diameter d, and wherein said shield has a generally circular shape with a diameter D, where D>d.
6. A device as claimed in claim 5 wherein said shield has a thickness t, and wherein D≧d+2t.
7. A device as claimed in claim 5 wherein the shield is formed of a material having a magnetic permeability relative to free space (μ) and has a thickness (t), where t>>D/μ.
8. A device as claimed in claim 1 wherein the shield is formed of a material having a magnetic permeability relative to free space (μ), has a major dimension X, and has a thickness (t) where t>>X/μ.
9. A device as claimed in claim 1 wherein said shield has a plurality of ventilation perforations formed therein.
10. A device as claimed in claim 9 wherein said perforations are formed parallel to the magnetic field direction.
11. A device as claimed in claim 10 wherein said primary coil is substantially circular, and wherein said perforations are a plurality of radial slots.
12. A device as claimed in claim 9 wherein said perforations cover approximately 25% to 75% of the area of the shield.
13. A device as claimed in claim 12 wherein said perforations cover approximately 50% of the area of the shield.
14. A device as claimed in claim 12 wherein the perforations result in a reduction in μs for the shield which is roughly proportional to the percentage of perforation area, and wherein the shield thickness is increased so as to maintain the relationship t>>D/μs.
15. A device as claimed in claim 12 wherein all dimensions for the perforations are less than the dimensions of the smallest coil in the device.
16. A device as claimed in claim 1 wherein said shield is flexible so as to be able to conform to the contours of a patient's body.
17. A device as claimed in claim 16 wherein said shield is formed of a low loss magnetic material in a flexible polymer matrix.
18. A device as claimed in claim 17 wherein said shield is formed of a ferrite powder in a silicone rubber.
19. A device as claimed in claim 16 wherein said shield is formed of a plurality of segments of a very high permeability material connected by a porous, flexible material.
20. A device as claimed in claim 19 wherein the spacings between adjacent segments in a direction substantially parallel to the magnetic field direction of the primary coil is less than the dimensions of the smallest coil in the device, and the spacing between adjacent segments in a direction substantially perpendicular to the magnetic field direction is much less than the spacing in said parallel direction.
21. A device as claimed in claim 19 wherein said segments cover approximately 25% to 75% of said shield area.
22. A device as claimed in claim 1 wherein said primary coil generates a magnetic field which is directed both toward and away from said secondary coil and wherein said shield is dimensioned and is formed of a material which reflects most of the magnetic filed directed thereto toward said secondary coil.
23. A device as claimed in claim 19 wherein said segments comprises:
a plurality of segments arranged in one or more concentric rings, each said concentric ring including segments of substantially the same size.
24. A device as claimed in claim 23 wherein said plurality of segments are constructed and arranged so as to form a gap between radially opposing segments in said ring, and wherein said segments further comprises a center disk shaped to fit within said gap.
25. A device a claimed in claim 1 , wherein said shield and said primary coil are mounted together to form a primary coil assembly, and wherein a substantially impervious coating is applied to said assembly.
26. A device a claimed in claim 25 , wherein said primary coil assembly is vinyl dip coated.
27. A device a claimed in claim 1 , wherein said primary coil is operationally decoupled from a drive circuit prior to physical disconnection of electrical contacts through which current is transferred from the drive circuitry to said primary coil, and wherein physical connection of electrical contacts through which current is transferred from the drive circuitry to said primary coil occurs prior to operationally coupled the primary winding to the drive circuit.
28. A device a claimed in claim 27 , wherein said primary coil is electrically coupled to the drive circuit via an electrical connector, wherein said electrical connector includes power transfer contacts and anti-arcing contacts, wherein said anti-arcing contacts electrically mate after and break before said power transfer contacts, said anti-arcing contacts electrically connected to control circuitry operationally interposed between the drive circuit from the primary winding.
29. A device a claimed in claim 28 , wherein said control circuitry is located in said drive circuitry.
30. A device a claimed in claim 28 , wherein said control circuitry is located in said connector.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/036,780 US20020058971A1 (en) | 1998-07-06 | 2001-12-31 | Cushioned primary coil for transcutaneous energy transfer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/110,608 US6324430B1 (en) | 1998-07-06 | 1998-07-06 | Magnetic shield for primary coil of transcutaneous energy transfer device |
US09/347,322 US6389318B1 (en) | 1998-07-06 | 1999-07-02 | Magnetic shield for primary coil of transcutaneous energy transfer device |
US10/036,780 US20020058971A1 (en) | 1998-07-06 | 2001-12-31 | Cushioned primary coil for transcutaneous energy transfer |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/347,322 Continuation US6389318B1 (en) | 1998-07-06 | 1999-07-02 | Magnetic shield for primary coil of transcutaneous energy transfer device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020058971A1 true US20020058971A1 (en) | 2002-05-16 |
Family
ID=26808218
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/347,322 Expired - Lifetime US6389318B1 (en) | 1998-07-06 | 1999-07-02 | Magnetic shield for primary coil of transcutaneous energy transfer device |
US10/036,780 Abandoned US20020058971A1 (en) | 1998-07-06 | 2001-12-31 | Cushioned primary coil for transcutaneous energy transfer |
US10/039,082 Abandoned US20020055763A1 (en) | 1998-07-06 | 2001-12-31 | Primary transcutaneous energy transfer coil with operational decoupling |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/347,322 Expired - Lifetime US6389318B1 (en) | 1998-07-06 | 1999-07-02 | Magnetic shield for primary coil of transcutaneous energy transfer device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/039,082 Abandoned US20020055763A1 (en) | 1998-07-06 | 2001-12-31 | Primary transcutaneous energy transfer coil with operational decoupling |
Country Status (5)
Country | Link |
---|---|
US (3) | US6389318B1 (en) |
EP (1) | EP1095384A1 (en) |
AU (1) | AU4861399A (en) |
CA (1) | CA2336725A1 (en) |
WO (1) | WO2000002212A1 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040098068A1 (en) * | 2002-06-28 | 2004-05-20 | Rafael Carbunaru | Chair pad charging and communication system for a battery-powered microstimulator |
US20050075698A1 (en) * | 2003-10-02 | 2005-04-07 | Medtronic, Inc. | Ambulatory energy transfer system for an implantable medical device and method therefore |
US20050245996A1 (en) * | 2004-04-30 | 2005-11-03 | Medtronic, Inc. | Spacers for use with transcutaneous energy transfer system |
US20070255223A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US20080263524A1 (en) * | 2005-09-09 | 2008-10-23 | International Business Machines Corporation | Method and System for State Machine Translation |
US9643022B2 (en) | 2013-06-17 | 2017-05-09 | Nyxoah SA | Flexible control housing for disposable patch |
US9849289B2 (en) | 2009-10-20 | 2017-12-26 | Nyxoah SA | Device and method for snoring detection and control |
US9855032B2 (en) | 2012-07-26 | 2018-01-02 | Nyxoah SA | Transcutaneous power conveyance device |
US9943686B2 (en) | 2009-10-20 | 2018-04-17 | Nyxoah SA | Method and device for treating sleep apnea based on tongue movement |
US10052097B2 (en) | 2012-07-26 | 2018-08-21 | Nyxoah SA | Implant unit delivery tool |
US10106046B2 (en) * | 2007-05-10 | 2018-10-23 | Auckland Uniservices Limited | Multi power source charging apparatus including inductive power transfer |
US10722631B2 (en) | 2018-02-01 | 2020-07-28 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
US10751537B2 (en) | 2009-10-20 | 2020-08-25 | Nyxoah SA | Arced implant unit for modulation of nerves |
US10814137B2 (en) | 2012-07-26 | 2020-10-27 | Nyxoah SA | Transcutaneous power conveyance device |
US11185677B2 (en) | 2017-06-07 | 2021-11-30 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11253712B2 (en) | 2012-07-26 | 2022-02-22 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8489200B2 (en) | 1998-07-06 | 2013-07-16 | Abiomed, Inc. | Transcutaneous energy transfer module with integrated conversion circuitry |
US6324431B1 (en) | 1998-07-06 | 2001-11-27 | Abiomed, Inc. | Transcutaneous energy transfer device with magnetic field protected components in secondary coil |
AU772100B2 (en) * | 1999-02-08 | 2004-04-08 | Cochlear Limited | Offset coils for radio frequency transcutaneous links |
US6895281B1 (en) * | 2000-03-31 | 2005-05-17 | Cardiac Pacemakers, Inc. | Inductive coil apparatus for bio-medical telemetry |
US6850803B1 (en) * | 2000-06-16 | 2005-02-01 | Medtronic, Inc. | Implantable medical device with a recharging coil magnetic shield |
US20020087204A1 (en) * | 2001-01-04 | 2002-07-04 | Kung Robert T. V. | Flexible transcutaneous energy transfer (TET) primary coil |
AUPR520301A0 (en) | 2001-05-23 | 2001-06-14 | Cochlear Limited | Transceiver coil for auditory prosthesis |
EP1547222B1 (en) | 2002-06-10 | 2018-10-03 | City University of Hong Kong | Planar inductive battery charger |
US8917057B2 (en) | 2002-06-10 | 2014-12-23 | City University Of Hong Kong | Battery charging system |
CA2497906C (en) * | 2002-09-20 | 2016-01-26 | Potencia Medical Ag | Harmless wireless energy transmission to implant |
US7153256B2 (en) | 2003-03-07 | 2006-12-26 | Neuronetics, Inc. | Reducing discomfort caused by electrical stimulation |
US8118722B2 (en) | 2003-03-07 | 2012-02-21 | Neuronetics, Inc. | Reducing discomfort caused by electrical stimulation |
US8811643B2 (en) | 2003-05-08 | 2014-08-19 | Advanced Bionics | Integrated cochlear implant headpiece |
GB0320960D0 (en) * | 2003-09-08 | 2003-10-08 | Splashpower Ltd | Improvements relating to improving flux patterns of inductive charging pads |
US7104947B2 (en) * | 2003-11-17 | 2006-09-12 | Neuronetics, Inc. | Determining stimulation levels for transcranial magnetic stimulation |
US7651459B2 (en) * | 2004-01-06 | 2010-01-26 | Neuronetics, Inc. | Method and apparatus for coil positioning for TMS studies |
US8177702B2 (en) | 2004-04-15 | 2012-05-15 | Neuronetics, Inc. | Method and apparatus for determining the proximity of a TMS coil to a subject's head |
US7601115B2 (en) * | 2004-05-24 | 2009-10-13 | Neuronetics, Inc. | Seizure therapy method and apparatus |
US7794499B2 (en) | 2004-06-08 | 2010-09-14 | Theken Disc, L.L.C. | Prosthetic intervertebral spinal disc with integral microprocessor |
US20050288740A1 (en) * | 2004-06-24 | 2005-12-29 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous telemetry to implanted medical device |
US7599743B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous energy transfer to implanted medical device |
US7599744B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Transcutaneous energy transfer primary coil with a high aspect ferrite core |
AU2011253672B2 (en) * | 2004-06-24 | 2013-05-16 | Ethicon Endo-Surgery, Inc. | Transcutaneous energy transfer primary coil with a high aspect ferrite core |
US7857746B2 (en) * | 2004-10-29 | 2010-12-28 | Nueronetics, Inc. | System and method to reduce discomfort using nerve stimulation |
US8088058B2 (en) * | 2005-01-20 | 2012-01-03 | Neuronetics, Inc. | Articulating arm |
US20060166376A1 (en) * | 2005-01-21 | 2006-07-27 | Craig Alan R | Compositions for use as a signal generation component and methods of using same |
US20060199159A1 (en) * | 2005-03-01 | 2006-09-07 | Neuronetics, Inc. | Head phantom for simulating the patient response to magnetic stimulation |
US7396326B2 (en) * | 2005-05-17 | 2008-07-08 | Neuronetics, Inc. | Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators |
US7824324B2 (en) | 2005-07-27 | 2010-11-02 | Neuronetics, Inc. | Magnetic core for medical procedures |
US11201500B2 (en) | 2006-01-31 | 2021-12-14 | Mojo Mobility, Inc. | Efficiencies and flexibilities in inductive (wireless) charging |
US8521303B2 (en) * | 2006-07-17 | 2013-08-27 | University Of Utah Reasearch Foundation | In vivo implantable coil assembly |
US8128549B2 (en) * | 2007-02-20 | 2012-03-06 | Neuronetics, Inc. | Capacitor failure detection |
WO2009023905A1 (en) * | 2007-08-17 | 2009-02-26 | Ventrassist Pty Ltd | Transcutaneous energy transfer coil assemblies and systems |
JP4453741B2 (en) * | 2007-10-25 | 2010-04-21 | トヨタ自動車株式会社 | Electric vehicle and vehicle power supply device |
US20090143673A1 (en) * | 2007-11-30 | 2009-06-04 | Transonic Systems Inc. | Transit time ultrasonic flow measurement |
AU2008331550B2 (en) * | 2007-11-30 | 2013-02-21 | Med-El Elektromedizinische Geraete Gmbh | Impact protector for an external element of a partially implantable system |
GB2457470A (en) * | 2008-02-13 | 2009-08-19 | Pulse Medical Technologies Ltd | Silver ion wound dressing with electromagnetic coil |
US8332040B1 (en) | 2008-03-10 | 2012-12-11 | Advanced Neuromodulation Systems, Inc. | External charging device for charging an implantable medical device and methods of regulating duty of cycle of an external charging device |
US9884200B2 (en) * | 2008-03-10 | 2018-02-06 | Neuronetics, Inc. | Apparatus for coil positioning for TMS studies |
US20110050164A1 (en) * | 2008-05-07 | 2011-03-03 | Afshin Partovi | System and methods for inductive charging, and improvements and uses thereof |
EP2355889B1 (en) | 2008-11-12 | 2013-12-18 | Advanced Bionics, LLC | Cochlear implant systems including magnetic flux redirection means |
US20100331918A1 (en) * | 2009-06-30 | 2010-12-30 | Boston Scientific Neuromodulation Corporation | Moldable charger with curable material for charging an implantable pulse generator |
TWI451458B (en) * | 2009-08-25 | 2014-09-01 | Access Business Group Int Llc | Flux concentrator and method of making a magnetic flux concentrator |
US9030159B2 (en) | 2010-03-26 | 2015-05-12 | Boston Scientific Neuromodulation Corporation | Inductive charger with magnetic shielding |
US8594806B2 (en) | 2010-04-30 | 2013-11-26 | Cyberonics, Inc. | Recharging and communication lead for an implantable device |
NZ586175A (en) * | 2010-06-15 | 2013-11-29 | Powerbyproxi Ltd | An icpt system, components and design method |
KR101192370B1 (en) | 2010-07-23 | 2012-10-17 | 유한회사 한림포스텍 | Wireless power transmission system, apparatus for suppying electric power wirelessly and apparatus for receiving electric power wirelessly |
US8766788B2 (en) | 2010-12-20 | 2014-07-01 | Abiomed, Inc. | Transcutaneous energy transfer system with vibration inducing warning circuitry |
ES2731918T3 (en) | 2010-12-20 | 2019-11-19 | Abiomed Inc | Transcutaneous energy transfer system with multiple secondary coils |
JP2014502528A (en) | 2010-12-20 | 2014-02-03 | アビオメド インコーポレイティド | Method and apparatus for accurately tracking charge available in a transdermal energy transmission system |
DE112010006090B4 (en) | 2010-12-24 | 2021-10-21 | Toyota Jidosha Kabushiki Kaisha | Contactless charging system, contactless charging method, contactless charging vehicle, and contactless charging management device |
DK3485819T3 (en) | 2011-04-14 | 2022-10-17 | Abiomed Inc | TRANSCUTANEOUS ENERGY TRANSFER COIL WITH INTEGRATED RADIO FREQUENCY ANTENNA |
US8884779B2 (en) | 2011-06-24 | 2014-11-11 | Medtronic, Inc. | EMI shield for medical device telemetry antenna |
DE102011083003B4 (en) * | 2011-09-20 | 2017-02-16 | Robert Bosch Gmbh | Hand tool device with at least one charging coil |
US9002468B2 (en) | 2011-12-16 | 2015-04-07 | Abiomed, Inc. | Automatic power regulation for transcutaneous energy transfer charging system |
WO2013095799A1 (en) * | 2011-12-21 | 2013-06-27 | Boston Scientific Neuromodulation Corporation | A system for an implantable medical device having an external charger coupleable to accessory charging coils |
WO2014018969A2 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Resonant power transfer system and method of estimating system state |
US10383990B2 (en) | 2012-07-27 | 2019-08-20 | Tc1 Llc | Variable capacitor for resonant power transfer systems |
US9805863B2 (en) | 2012-07-27 | 2017-10-31 | Thoratec Corporation | Magnetic power transmission utilizing phased transmitter coil arrays and phased receiver coil arrays |
WO2014018971A1 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Resonant power transfer systems with protective algorithm |
EP2878062A4 (en) | 2012-07-27 | 2016-04-20 | Thoratec Corp | Resonant power transmission coils and systems |
WO2014018972A1 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Computer modeling for resonant power transfer systems |
US9287040B2 (en) | 2012-07-27 | 2016-03-15 | Thoratec Corporation | Self-tuning resonant power transfer systems |
EP4257174A3 (en) | 2012-07-27 | 2023-12-27 | Tc1 Llc | Thermal management for implantable wireless power transfer systems |
US9343923B2 (en) | 2012-08-23 | 2016-05-17 | Cyberonics, Inc. | Implantable medical device with backscatter signal based communication |
US9935498B2 (en) | 2012-09-25 | 2018-04-03 | Cyberonics, Inc. | Communication efficiency with an implantable medical device using a circulator and a backscatter signal |
US9680310B2 (en) | 2013-03-15 | 2017-06-13 | Thoratec Corporation | Integrated implantable TETS housing including fins and coil loops |
EP3490102B1 (en) * | 2013-03-15 | 2020-08-05 | Tc1 Llc | Malleable tets coil with improved anatomical fit |
WO2014158034A1 (en) * | 2013-03-27 | 2014-10-02 | Auckland Uniservices Limited | Electromagnetic field confinement |
US9780596B2 (en) | 2013-07-29 | 2017-10-03 | Alfred E. Mann Foundation For Scientific Research | Microprocessor controlled class E driver |
CA2919525C (en) | 2013-07-29 | 2021-07-20 | Alfred E. Mann Foundation For Scientific Research | High efficiency magnetic link for implantable devices |
US10615642B2 (en) | 2013-11-11 | 2020-04-07 | Tc1 Llc | Resonant power transfer systems with communications |
US10695476B2 (en) | 2013-11-11 | 2020-06-30 | Tc1 Llc | Resonant power transfer systems with communications |
JP6516765B2 (en) | 2013-11-11 | 2019-05-22 | ティーシー1 エルエルシー | Resonant power transmission coil with hinge |
DE102014000738A1 (en) * | 2014-01-21 | 2015-08-06 | Audi Ag | Shielding device for shielding electromagnetic radiation in a contactless energy transmission, energy transmission device and arrangement for contactless energy transmission |
US10610692B2 (en) | 2014-03-06 | 2020-04-07 | Tc1 Llc | Electrical connectors for implantable devices |
US9061216B1 (en) | 2014-04-07 | 2015-06-23 | Factor 10 LLC | Induction light toy and related methods |
EP3131623B1 (en) | 2014-04-15 | 2018-06-06 | Heartware, Inc. | Improvements in transcutaneous energy transfer systems |
WO2015160806A2 (en) | 2014-04-15 | 2015-10-22 | Heartware, Inc. | Improvements in transcutaneous energy transfer systems |
US10668295B2 (en) * | 2014-04-25 | 2020-06-02 | Mr3 Medical, Llc | Energy harvesting stimulator |
US9855376B2 (en) | 2014-07-25 | 2018-01-02 | Minnetronix, Inc. | Power scaling |
DE102015112098A1 (en) | 2014-07-25 | 2016-01-28 | Minnetronix, Inc. | Coil parameters and control |
EP4213298A1 (en) | 2014-09-22 | 2023-07-19 | Tc1 Llc | Antenna designs for communication between a wirelessly powered implant to an external device outside the body |
US9583874B2 (en) | 2014-10-06 | 2017-02-28 | Thoratec Corporation | Multiaxial connector for implantable devices |
DE102016100476A1 (en) | 2015-01-14 | 2016-07-14 | Minnetronix, Inc. | Decentralized transformer |
DE102016100534A1 (en) | 2015-01-16 | 2016-07-21 | Vlad BLUVSHTEIN | Data transmission in a transcutaneous energy transmission system |
US10193395B2 (en) | 2015-04-14 | 2019-01-29 | Minnetronix, Inc. | Repeater resonator |
US10148126B2 (en) | 2015-08-31 | 2018-12-04 | Tc1 Llc | Wireless energy transfer system and wearables |
US10181757B2 (en) | 2015-09-17 | 2019-01-15 | Qualcomm Incorporated | Apparatus and methods for shielding a wireless power transmitter |
US10177604B2 (en) | 2015-10-07 | 2019-01-08 | Tc1 Llc | Resonant power transfer systems having efficiency optimization based on receiver impedance |
US10226637B2 (en) | 2016-06-15 | 2019-03-12 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device having alignment and centering capabilities |
US10363426B2 (en) | 2016-06-15 | 2019-07-30 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device for determining position using phase angle or a plurality of parameters as determined from at least one sense coil |
US11129996B2 (en) | 2016-06-15 | 2021-09-28 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device for determining position and optimizing power transmission using resonant frequency as determined from at least one sense coil |
US11471692B2 (en) | 2016-06-15 | 2022-10-18 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device for adjusting charging power based on determined position using at least one sense coil |
US10342984B2 (en) | 2016-06-15 | 2019-07-09 | Boston Scientific Neuromodulation Corporation | Split coil for uniform magnetic field generation from an external charger for an implantable medical device |
US10603501B2 (en) | 2016-06-15 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device having at least one sense coil concentric with a charging coil for determining position |
US10898292B2 (en) | 2016-09-21 | 2021-01-26 | Tc1 Llc | Systems and methods for locating implanted wireless power transmission devices |
US11197990B2 (en) | 2017-01-18 | 2021-12-14 | Tc1 Llc | Systems and methods for transcutaneous power transfer using microneedles |
US10632318B2 (en) | 2017-03-21 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | External charger with three-axis magnetic field sensor to determine implantable medical device position |
US11426091B2 (en) | 2017-09-06 | 2022-08-30 | Apple Inc. | Film coatings as electrically conductive pathways |
US10491041B2 (en) * | 2017-09-06 | 2019-11-26 | Apple Inc. | Single-structure wireless charging receiver systems having multiple receiver coils |
US10381881B2 (en) | 2017-09-06 | 2019-08-13 | Apple Inc. | Architecture of portable electronic devices with wireless charging receiver systems |
EP3735733B1 (en) | 2018-01-04 | 2024-01-17 | Tc1 Llc | Systems and methods for elastic wireless power transmission devices |
DE102018201030A1 (en) | 2018-01-24 | 2019-07-25 | Kardion Gmbh | Magnetic coupling element with magnetic bearing function |
CN108494103A (en) * | 2018-03-19 | 2018-09-04 | 武汉大学 | A kind of design method of novel radio electric energy transmission coil shielding construction |
DE102018206754A1 (en) | 2018-05-02 | 2019-11-07 | Kardion Gmbh | Method and device for determining the temperature at a surface and use of the method |
DE102018206724A1 (en) | 2018-05-02 | 2019-11-07 | Kardion Gmbh | Energy transmission system and method for wireless energy transmission |
US11642537B2 (en) | 2019-03-11 | 2023-05-09 | Axonics, Inc. | Charging device with off-center coil |
US11699551B2 (en) | 2020-11-05 | 2023-07-11 | Kardion Gmbh | Device for inductive energy transmission in a human body and use of the device |
Citations (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3195540A (en) * | 1963-03-29 | 1965-07-20 | Louis C Waller | Power supply for body implanted instruments |
US3357432A (en) * | 1965-02-09 | 1967-12-12 | Edwards Lab Inc | Anastomotic coupling |
US3824129A (en) * | 1973-03-14 | 1974-07-16 | Mallory & Co Inc P R | Heart pacer rechargeable cell and protective control system |
US3888260A (en) * | 1972-06-28 | 1975-06-10 | Univ Johns Hopkins | Rechargeable demand inhibited cardiac pacer and tissue stimulator |
US3934177A (en) * | 1975-01-09 | 1976-01-20 | Stephen Horbach | Heat sink casing for circuit board components |
US3942535A (en) * | 1973-09-27 | 1976-03-09 | G. D. Searle & Co. | Rechargeable tissue stimulating system |
US4012769A (en) * | 1975-08-04 | 1977-03-15 | Thermalloy Incorporated | Heat sink with parallel flat faces |
US4041955A (en) * | 1976-01-29 | 1977-08-16 | Pacesetter Systems Inc. | Implantable living tissue stimulator with an improved hermetic metal container |
US4068292A (en) * | 1975-03-27 | 1978-01-10 | International Medical Electronics, Inc. | Electrostatic shield for diathermy treatment head |
US4071032A (en) * | 1976-01-29 | 1978-01-31 | Pacesetter Systems Inc. | Implantable living tissue stimulators |
US4104701A (en) * | 1976-11-22 | 1978-08-01 | Powercube Corporation | Mounting assembly for electronic power devices |
US4266533A (en) * | 1976-11-17 | 1981-05-12 | Electro-Biology, Inc. | Modification of the growth, repair and maintenance behavior of living tissues and cells by a specific and selective change in electrical environment |
US4423308A (en) * | 1981-06-22 | 1983-12-27 | Simmons U.S.A. Corporation | Thermally controllable heating mattress |
US4441498A (en) * | 1982-05-10 | 1984-04-10 | Cardio-Pace Medical, Inc. | Planar receiver antenna coil for programmable electromedical pulse generator |
US4517585A (en) * | 1982-08-13 | 1985-05-14 | Lucas Chloride Ev Systems Limited | Heat sink for semi-conductor devices having terminals projecting from a heat sink transfer face |
US4539433A (en) * | 1982-11-24 | 1985-09-03 | Tdk Corporation | Electromagnetic shield |
US4586508A (en) * | 1984-03-23 | 1986-05-06 | Cordis Corporation | Implant communication system with patient coil |
US4603445A (en) * | 1983-09-09 | 1986-08-05 | Span-America Medical Systems, Inc. | Support pad and method of manufacture |
US4665896A (en) * | 1985-07-22 | 1987-05-19 | Novacor Medical Corporation | Power supply for body implant and method of use |
US4679560A (en) * | 1985-04-02 | 1987-07-14 | Board Of Trustees Of The Leland Stanford Junior University | Wide band inductive transdermal power and data link |
US4741339A (en) * | 1984-10-22 | 1988-05-03 | Cochlear Pty. Limited | Power transfer for implanted prostheses |
US4901387A (en) * | 1988-03-21 | 1990-02-20 | Luke John K | Mattress overlay with individual foam springs |
US4944299A (en) * | 1989-08-08 | 1990-07-31 | Siemens-Pacesetter, Inc. | High speed digital telemetry system for implantable device |
US5000178A (en) * | 1986-05-23 | 1991-03-19 | Lti Biomedical, Inc. | Shielded electromagnetic transducer |
US5007124A (en) * | 1988-11-04 | 1991-04-16 | Span-America Medical Systems, Inc. | Support pad with uniform patterned surface |
US5214392A (en) * | 1988-11-08 | 1993-05-25 | Murata Mfg. Co., Ltd. | Multilayered ceramic type electromagnetic coupler apparatus |
US5312439A (en) * | 1991-12-12 | 1994-05-17 | Loeb Gerald E | Implantable device having an electrolytic storage electrode |
US5324316A (en) * | 1991-12-18 | 1994-06-28 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5327597A (en) * | 1992-07-02 | 1994-07-12 | Michael Rothbard | Convoluted mattress pad having multiple proximate peaks |
US5358514A (en) * | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5411537A (en) * | 1993-10-29 | 1995-05-02 | Intermedics, Inc. | Rechargeable biomedical battery powered devices with recharging and control system therefor |
US5459896A (en) * | 1992-06-24 | 1995-10-24 | Span-America Medical Systems, Inc. | Wheelchair cushion and cover |
US5527348A (en) * | 1995-02-03 | 1996-06-18 | Medtronic, Inc. | Magnetically permeable E-shield and method of connection thereto |
US5545191A (en) * | 1994-05-06 | 1996-08-13 | Alfred E. Mann Foundation For Scientific Research | Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body |
US5621369A (en) * | 1995-09-18 | 1997-04-15 | Gardner; Harris L. | Flexible magnet |
US5740257A (en) * | 1996-12-19 | 1998-04-14 | Lucent Technologies Inc. | Active noise control earpiece being compatible with magnetic coupled hearing aids |
US5948006A (en) * | 1998-10-14 | 1999-09-07 | Advanced Bionics Corporation | Transcutaneous transmission patch |
US5951459A (en) * | 1997-08-29 | 1999-09-14 | Orthosoft, L.L.C. | Magnetic coil for pulsed electromagnetic field |
US5959522A (en) * | 1998-02-03 | 1999-09-28 | Motorola, Inc. | Integrated electromagnetic device and method |
US6048601A (en) * | 1997-01-20 | 2000-04-11 | Daido Steel Co., Ltd. | Soft magnetic alloy powder for electromagnetic and magnetic shield, and shielding members containing the same |
US6061596A (en) * | 1995-11-24 | 2000-05-09 | Advanced Bionics Corporation | Method for conditioning pelvic musculature using an implanted microstimulator |
US6212430B1 (en) * | 1999-05-03 | 2001-04-03 | Abiomed, Inc. | Electromagnetic field source with detection of position of secondary coil in relation to multiple primary coils |
US6240316B1 (en) * | 1998-08-14 | 2001-05-29 | Advanced Bionics Corporation | Implantable microstimulation system for treatment of sleep apnea |
US6275737B1 (en) * | 1998-10-14 | 2001-08-14 | Advanced Bionics Corporation | Transcutaneous transmission pouch |
US6324431B1 (en) * | 1998-07-06 | 2001-11-27 | Abiomed, Inc. | Transcutaneous energy transfer device with magnetic field protected components in secondary coil |
US6324430B1 (en) * | 1998-07-06 | 2001-11-27 | Abiomed, Inc. | Magnetic shield for primary coil of transcutaneous energy transfer device |
US6735474B1 (en) * | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4628392A (en) * | 1983-12-20 | 1986-12-09 | Biw Cable Systems, Inc. | Explosion proof electrical connector system with quick power disconnect |
DE69210458T2 (en) | 1991-01-30 | 1996-09-05 | Boeing Co | Bus coupler in current mode with flat coils and shields |
JPH0746164A (en) | 1993-07-26 | 1995-02-14 | Tokin Corp | Magnetic communication equipment |
US5542425A (en) * | 1994-12-20 | 1996-08-06 | Acuson Corporation | Apparatus and method for preventing contact damage in electrical equipment |
-
1999
- 1999-07-02 US US09/347,322 patent/US6389318B1/en not_active Expired - Lifetime
- 1999-07-06 EP EP99932272A patent/EP1095384A1/en not_active Withdrawn
- 1999-07-06 WO PCT/US1999/015228 patent/WO2000002212A1/en not_active Application Discontinuation
- 1999-07-06 CA CA002336725A patent/CA2336725A1/en not_active Abandoned
- 1999-07-06 AU AU48613/99A patent/AU4861399A/en not_active Abandoned
-
2001
- 2001-12-31 US US10/036,780 patent/US20020058971A1/en not_active Abandoned
- 2001-12-31 US US10/039,082 patent/US20020055763A1/en not_active Abandoned
Patent Citations (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3195540A (en) * | 1963-03-29 | 1965-07-20 | Louis C Waller | Power supply for body implanted instruments |
US3357432A (en) * | 1965-02-09 | 1967-12-12 | Edwards Lab Inc | Anastomotic coupling |
US3888260A (en) * | 1972-06-28 | 1975-06-10 | Univ Johns Hopkins | Rechargeable demand inhibited cardiac pacer and tissue stimulator |
US3824129A (en) * | 1973-03-14 | 1974-07-16 | Mallory & Co Inc P R | Heart pacer rechargeable cell and protective control system |
US3942535A (en) * | 1973-09-27 | 1976-03-09 | G. D. Searle & Co. | Rechargeable tissue stimulating system |
US3934177A (en) * | 1975-01-09 | 1976-01-20 | Stephen Horbach | Heat sink casing for circuit board components |
US4068292A (en) * | 1975-03-27 | 1978-01-10 | International Medical Electronics, Inc. | Electrostatic shield for diathermy treatment head |
US4012769A (en) * | 1975-08-04 | 1977-03-15 | Thermalloy Incorporated | Heat sink with parallel flat faces |
US4041955A (en) * | 1976-01-29 | 1977-08-16 | Pacesetter Systems Inc. | Implantable living tissue stimulator with an improved hermetic metal container |
US4071032A (en) * | 1976-01-29 | 1978-01-31 | Pacesetter Systems Inc. | Implantable living tissue stimulators |
US4266533A (en) * | 1976-11-17 | 1981-05-12 | Electro-Biology, Inc. | Modification of the growth, repair and maintenance behavior of living tissues and cells by a specific and selective change in electrical environment |
US4104701A (en) * | 1976-11-22 | 1978-08-01 | Powercube Corporation | Mounting assembly for electronic power devices |
US4423308A (en) * | 1981-06-22 | 1983-12-27 | Simmons U.S.A. Corporation | Thermally controllable heating mattress |
US4441498A (en) * | 1982-05-10 | 1984-04-10 | Cardio-Pace Medical, Inc. | Planar receiver antenna coil for programmable electromedical pulse generator |
US4517585A (en) * | 1982-08-13 | 1985-05-14 | Lucas Chloride Ev Systems Limited | Heat sink for semi-conductor devices having terminals projecting from a heat sink transfer face |
US4539433A (en) * | 1982-11-24 | 1985-09-03 | Tdk Corporation | Electromagnetic shield |
US4603445A (en) * | 1983-09-09 | 1986-08-05 | Span-America Medical Systems, Inc. | Support pad and method of manufacture |
US4586508A (en) * | 1984-03-23 | 1986-05-06 | Cordis Corporation | Implant communication system with patient coil |
US4741339A (en) * | 1984-10-22 | 1988-05-03 | Cochlear Pty. Limited | Power transfer for implanted prostheses |
US4679560A (en) * | 1985-04-02 | 1987-07-14 | Board Of Trustees Of The Leland Stanford Junior University | Wide band inductive transdermal power and data link |
US4665896A (en) * | 1985-07-22 | 1987-05-19 | Novacor Medical Corporation | Power supply for body implant and method of use |
US5000178A (en) * | 1986-05-23 | 1991-03-19 | Lti Biomedical, Inc. | Shielded electromagnetic transducer |
US4901387A (en) * | 1988-03-21 | 1990-02-20 | Luke John K | Mattress overlay with individual foam springs |
US5007124A (en) * | 1988-11-04 | 1991-04-16 | Span-America Medical Systems, Inc. | Support pad with uniform patterned surface |
US5214392A (en) * | 1988-11-08 | 1993-05-25 | Murata Mfg. Co., Ltd. | Multilayered ceramic type electromagnetic coupler apparatus |
US4944299A (en) * | 1989-08-08 | 1990-07-31 | Siemens-Pacesetter, Inc. | High speed digital telemetry system for implantable device |
US5312439A (en) * | 1991-12-12 | 1994-05-17 | Loeb Gerald E | Implantable device having an electrolytic storage electrode |
US5324316A (en) * | 1991-12-18 | 1994-06-28 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5358514A (en) * | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5459896A (en) * | 1992-06-24 | 1995-10-24 | Span-America Medical Systems, Inc. | Wheelchair cushion and cover |
US5327597A (en) * | 1992-07-02 | 1994-07-12 | Michael Rothbard | Convoluted mattress pad having multiple proximate peaks |
US5411537A (en) * | 1993-10-29 | 1995-05-02 | Intermedics, Inc. | Rechargeable biomedical battery powered devices with recharging and control system therefor |
US5545191A (en) * | 1994-05-06 | 1996-08-13 | Alfred E. Mann Foundation For Scientific Research | Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body |
US5527348A (en) * | 1995-02-03 | 1996-06-18 | Medtronic, Inc. | Magnetically permeable E-shield and method of connection thereto |
US5621369A (en) * | 1995-09-18 | 1997-04-15 | Gardner; Harris L. | Flexible magnet |
US6061596A (en) * | 1995-11-24 | 2000-05-09 | Advanced Bionics Corporation | Method for conditioning pelvic musculature using an implanted microstimulator |
US5740257A (en) * | 1996-12-19 | 1998-04-14 | Lucent Technologies Inc. | Active noise control earpiece being compatible with magnetic coupled hearing aids |
US6048601A (en) * | 1997-01-20 | 2000-04-11 | Daido Steel Co., Ltd. | Soft magnetic alloy powder for electromagnetic and magnetic shield, and shielding members containing the same |
US5951459A (en) * | 1997-08-29 | 1999-09-14 | Orthosoft, L.L.C. | Magnetic coil for pulsed electromagnetic field |
US5959522A (en) * | 1998-02-03 | 1999-09-28 | Motorola, Inc. | Integrated electromagnetic device and method |
US6324431B1 (en) * | 1998-07-06 | 2001-11-27 | Abiomed, Inc. | Transcutaneous energy transfer device with magnetic field protected components in secondary coil |
US6735474B1 (en) * | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
US6324430B1 (en) * | 1998-07-06 | 2001-11-27 | Abiomed, Inc. | Magnetic shield for primary coil of transcutaneous energy transfer device |
US6240316B1 (en) * | 1998-08-14 | 2001-05-29 | Advanced Bionics Corporation | Implantable microstimulation system for treatment of sleep apnea |
US5948006A (en) * | 1998-10-14 | 1999-09-07 | Advanced Bionics Corporation | Transcutaneous transmission patch |
US6275737B1 (en) * | 1998-10-14 | 2001-08-14 | Advanced Bionics Corporation | Transcutaneous transmission pouch |
US6212430B1 (en) * | 1999-05-03 | 2001-04-03 | Abiomed, Inc. | Electromagnetic field source with detection of position of secondary coil in relation to multiple primary coils |
Cited By (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8185212B2 (en) | 2002-06-28 | 2012-05-22 | Boston Scientific Neuromodulation Corporation | Chair pad charging and communication system for a battery-powered microstimulator |
US20040098068A1 (en) * | 2002-06-28 | 2004-05-20 | Rafael Carbunaru | Chair pad charging and communication system for a battery-powered microstimulator |
US8543216B2 (en) | 2002-06-28 | 2013-09-24 | Boston Scientific Neuromodulation Corporation | Charging and communication system for a battery-powered microstimulator |
US20100298910A1 (en) * | 2002-06-28 | 2010-11-25 | Boston Scientific Neuromodulation Corporation | Chair Pad Charging and Communication System for a Battery-Powered Microstimulator |
US20050075698A1 (en) * | 2003-10-02 | 2005-04-07 | Medtronic, Inc. | Ambulatory energy transfer system for an implantable medical device and method therefore |
WO2005037369A1 (en) * | 2003-10-02 | 2005-04-28 | Medtronic, Inc. | Ambulatory energy transfer system for an implantable medical device and method therefore |
US7515967B2 (en) | 2003-10-02 | 2009-04-07 | Medtronic, Inc. | Ambulatory energy transfer system for an implantable medical device and method therefore |
US20050245996A1 (en) * | 2004-04-30 | 2005-11-03 | Medtronic, Inc. | Spacers for use with transcutaneous energy transfer system |
WO2005110540A1 (en) * | 2004-04-30 | 2005-11-24 | Medtronic, Inc. | Spacers for use with transcutaneous energy transfer system |
US8880184B2 (en) | 2004-04-30 | 2014-11-04 | Medtronic, Inc. | Spacers for use with transcutaneous energy transfer system |
US7512443B2 (en) | 2004-04-30 | 2009-03-31 | Medtronic, Inc. | Spacers for use with transcutaneous energy transfer system |
US20080263524A1 (en) * | 2005-09-09 | 2008-10-23 | International Business Machines Corporation | Method and System for State Machine Translation |
US7925357B2 (en) | 2006-04-28 | 2011-04-12 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US20070255223A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US7738965B2 (en) | 2006-04-28 | 2010-06-15 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US8706255B2 (en) | 2006-04-28 | 2014-04-22 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US20070257636A1 (en) * | 2006-04-28 | 2007-11-08 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US10106046B2 (en) * | 2007-05-10 | 2018-10-23 | Auckland Uniservices Limited | Multi power source charging apparatus including inductive power transfer |
US11857791B2 (en) | 2009-10-20 | 2024-01-02 | Nyxoah SA | Arced implant unit for modulation of nerves |
US9849289B2 (en) | 2009-10-20 | 2017-12-26 | Nyxoah SA | Device and method for snoring detection and control |
US11273307B2 (en) | 2009-10-20 | 2022-03-15 | Nyxoah SA | Method and device for treating sleep apnea |
US9943686B2 (en) | 2009-10-20 | 2018-04-17 | Nyxoah SA | Method and device for treating sleep apnea based on tongue movement |
US9950166B2 (en) | 2009-10-20 | 2018-04-24 | Nyxoah SA | Acred implant unit for modulation of nerves |
US10716940B2 (en) | 2009-10-20 | 2020-07-21 | Nyxoah SA | Implant unit for modulation of small diameter nerves |
US10898717B2 (en) | 2009-10-20 | 2021-01-26 | Nyxoah SA | Device and method for snoring detection and control |
US10751537B2 (en) | 2009-10-20 | 2020-08-25 | Nyxoah SA | Arced implant unit for modulation of nerves |
US10052097B2 (en) | 2012-07-26 | 2018-08-21 | Nyxoah SA | Implant unit delivery tool |
US9855032B2 (en) | 2012-07-26 | 2018-01-02 | Nyxoah SA | Transcutaneous power conveyance device |
US10716560B2 (en) | 2012-07-26 | 2020-07-21 | Nyxoah SA | Implant unit delivery tool |
US10814137B2 (en) | 2012-07-26 | 2020-10-27 | Nyxoah SA | Transcutaneous power conveyance device |
US11730469B2 (en) | 2012-07-26 | 2023-08-22 | Nyxoah SA | Implant unit delivery tool |
US10918376B2 (en) | 2012-07-26 | 2021-02-16 | Nyxoah SA | Therapy protocol activation triggered based on initial coupling |
US11253712B2 (en) | 2012-07-26 | 2022-02-22 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
US11298549B2 (en) | 2013-06-17 | 2022-04-12 | Nyxoah SA | Control housing for disposable patch |
US11642534B2 (en) | 2013-06-17 | 2023-05-09 | Nyxoah SA | Programmable external control unit |
US10512782B2 (en) | 2013-06-17 | 2019-12-24 | Nyxoah SA | Remote monitoring and updating of a medical device control unit |
US9643022B2 (en) | 2013-06-17 | 2017-05-09 | Nyxoah SA | Flexible control housing for disposable patch |
US11185677B2 (en) | 2017-06-07 | 2021-11-30 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11717670B2 (en) | 2017-06-07 | 2023-08-08 | Shifamed Holdings, LLP | Intravascular fluid movement devices, systems, and methods of use |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11229784B2 (en) | 2018-02-01 | 2022-01-25 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
US10722631B2 (en) | 2018-02-01 | 2020-07-28 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
Also Published As
Publication number | Publication date |
---|---|
AU4861399A (en) | 2000-01-24 |
US6389318B1 (en) | 2002-05-14 |
EP1095384A1 (en) | 2001-05-02 |
US20020055763A1 (en) | 2002-05-09 |
WO2000002212A1 (en) | 2000-01-13 |
CA2336725A1 (en) | 2000-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6389318B1 (en) | Magnetic shield for primary coil of transcutaneous energy transfer device | |
US6324430B1 (en) | Magnetic shield for primary coil of transcutaneous energy transfer device | |
US6895281B1 (en) | Inductive coil apparatus for bio-medical telemetry | |
US20020087204A1 (en) | Flexible transcutaneous energy transfer (TET) primary coil | |
US11065462B2 (en) | Wireless recharging system and method for flexible implantable subcutaneous medical device | |
US7493167B2 (en) | Magnetically shielded AIMD housing with window for magnetically actuated switch | |
US9333367B2 (en) | Charger with orthogonal PCB for implantable medical device | |
US8543216B2 (en) | Charging and communication system for a battery-powered microstimulator | |
US4143661A (en) | Power supply for body implant and method for operation | |
US7283867B2 (en) | Implantable system and methods for acquisition and processing of electrical signals from muscles and/or nerves and/or central nervous system tissue | |
US8923968B2 (en) | Power link for implantable devices | |
CA2721393C (en) | Conductive coating of implants with inductive link | |
US20050288743A1 (en) | Implantable medical device with contactless power transfer housing | |
US9531195B2 (en) | Inductively rechargeable implantable device with reduced eddy currents | |
US20070096686A1 (en) | Implantable device with heat absorption material | |
WO2011079309A2 (en) | Neural stimulation devices and systems for treatment of chronic inflammation | |
US8594806B2 (en) | Recharging and communication lead for an implantable device | |
Lucke et al. | Safety considerations for wireless delivery of continuous power to implanted medical devices | |
EP2456516B1 (en) | Magnetic switching device with a switch formed by an electrocautery pen | |
CN219355104U (en) | Pulse generator and nerve stimulator | |
JPS6373952A (en) | Power transmission for artificial organ | |
CN116937825A (en) | Wireless charging device and implanted medical system thereof | |
JP2004081247A (en) | Intracorporeal implanting type equipment system, and its resetting method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |